[1]王 园,杨 允,王 博,等.基于网络药理学和动物实验探讨益肺解毒颗粒对急性肺损伤小鼠炎症反应及免疫功能的影响[J].陕西中医,2024,(12):1619-1624.[doi:DOI:10.3969/j.issn.1000-7369.2024.12.007]
 WANG Yuan,YANG Yun,WANG Bo,et al.Protective effects of Yifei Jiedu granules on inflammatory response and immune function with acute lung injury in mice based on network pharmacology and animal experiments[J].,2024,(12):1619-1624.[doi:DOI:10.3969/j.issn.1000-7369.2024.12.007]
点击复制

基于网络药理学和动物实验探讨益肺解毒颗粒对急性肺损伤小鼠炎症反应及免疫功能的影响
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年12期
页码:
1619-1624
栏目:
临床研究
出版日期:
2024-12-05

文章信息/Info

Title:
Protective effects of Yifei Jiedu granules on inflammatory response and immune function with acute lung injury in mice based on network pharmacology and animal experiments
作者:
王 园1杨 允2王 博2马战平3杨栓柱3刘 洋1龙凯花1王海峰4
(1.陕西省中医药研究院,陕西 西安 710003; 2.西北大学,陕西 西安 710069; 3.陕西省中医医院,陕西 西安 710003; 4.武警陕西省总队医院,陕西 西安 710054)
Author(s):
WANG YuanYANG YunWANG BoMA ZhanpingYANG ShuanzhuLIU YangLONG KaihuaWANG Haifeng
(Shaanxi Academy of Traditional Chinese Medicine,Xi'an 710003,China)
关键词:
急性肺损伤 益肺解毒颗粒 网络药理学 脂多糖 炎症因子 免疫功能
Keywords:
Acute lung injury Yifei Jiedu granules Network pharmacology Lipopolysaccharide Inflammatory cytokine Immune function
分类号:
R 563
DOI:
DOI:10.3969/j.issn.1000-7369.2024.12.007
文献标志码:
A
摘要:
目的:通过网络药理学和动物实验探讨益肺解毒颗粒对脂多糖(LPS)所致急性肺损伤(ALI)小鼠的影响及保护作用。方法:利用Swiss Target Prediction等平台,对药物的靶点进行筛选; 利用Gene Cards数据库以“acute lung injury”为关键词整理疾病靶点; 利用STRING平台进行蛋白互作分析,Cytoscape 3.7.2可视化交集靶点网络图并对核心靶点筛选; 微生信平台进行KEGG通路富集和GO分析,Cytoscape 3.7.2构建成分-靶点-通路网络图。将30只C57小鼠随机分为空白组、模型组和低、中、高剂量组,模型及给药组采用LPS气管内滴注的方法建立ALI模型。记录小鼠体重变化; 测定胸腺与脾脏指数; 测定血清和肺泡灌洗液(BALF)中白介素-6(IL-6)、白介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)的含量; HE染色法观察肺组织病理变化。结果:筛选后获得药物靶点277个,成分与疾病的交集靶点146个,关键靶点有CASP3、EGFR、ESR1等,GO功能结果共1766个,KEGG富集结果有178条通路,PI3K-Akt信号通路为关键通路。相较空白组,模型组的胸腺与脾脏指数显著下降(均P<0.05); 血清与BALF中IL-6、IL-1β、TNF-α含量显著增加(均P<0.05); 肺组织明显出现炎性细胞浸润和出血。与模型组相比,给药组的胸腺指数显著增加(均P<0.05); 高剂量组血清和BALF中炎症因子含量显著降低(均P<0.05)。结论:益肺解毒颗粒能改善因LPS所致的ALI小鼠肺组织病理损伤,其机制可能与增强免疫功能和抑制炎症因子分泌有关。
Abstract:
Objective:To investigate the protective effects of Yifei Jiedu granules lipopolysaccharide-induced acute lung injury in mice based on network pharmacology and animal experiments.Methods:Using Swiss Target Prediction platformetc,drug targets were screened.Using Gene Cards database and using “acute lung injury” as the key words to collate disease targets.The STRING platform was used for protein interaction analysis,and Cytoscape 3.7.2 software was used to visualize the intersection target network diagram and screen the core targets.Weishengxin platform were used for KEGG pathway enrichment and GO analysis.The components-targets-pathways network diagram is constructed using Cytoscape 3.7.2.Thirty male C57 mice were randomly divided into the blank group,the model group,and the Yifei Jiedu granules low,medium,high-dose groups,the model of acute lung injury was established by endotracheal infusion of LPS in the model group,and the Yifei Jiedu granules low,medium,high-dose groups.The weight of mice,thymus index and spleen index were analyzed.The levels of IL-6,IL-1β,TNF-α in serum and bronchoalveolar lavage fluid were determined.HE staining was used to observe the lung tissues histopathological changes.Results:After screening,277 gene targets of Yifei Jiedu granules were obtained,there were 146 intersection targets between components and disease,among which the key targets included CASP3,EGFR,ESR1 etc.There were 1766 results in GO function,178 mechanism pathways were obtained by KEGG enrichment analysis.The PI3K-Akt signal pathway is the key pathway.Compared with the blank group,the thymus index and spleen index in the model group were decreased(P<0.05),the levels of three inflammatory cytokine in serum and BALF were increased(P<0.05),the lung tissue with inflammatory cell infiltration and bleeding.Compared with the model group,the thymus index in medication administration groups was increased(all P<0.05),the levels of inflammatory cytokine in Yifei Jiedu granules high-dose group in serum and BALF were decreased(P<0.05).Conclusion:Yifei Jiedu granules can improve the pathological injury of ALI mice induced by LPS.The mechanism may be related to enhancing immune function and inhibiting the levels of inflammatory cytokine in the lungs.

参考文献/References:

[1] CHEN H,BAI C,WANG X.The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine[J].Expert Rev Respir Med,2010,4(6):773-783.
[2] LONG M E,MALLAMPALLI R K,HOROWITZ J C.Pathogenesis of pneumonia and acute lung injury[J].Clin Sci,2022,136(10):747-769.
[3] MA A,FENG Z,LI Y,et al.Ferroptosis-related signature and immune infiltration characterization in acute lung injury/acute respiratory distress syndrome[J].Respir Res,2023,24(1):154.
[4] 潘蕊,乔秋杰,曾江楠,等.基于JAK2-STAT3信号通路探讨热毒宁注射液治疗大鼠急性肺损伤的作用机制[J].陕西中医,2024,45(8):1021-1025.
[5] HE Y Q,ZHOU C C,YU L Y,et al.Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms[J].Pharmacol Res,2021,163:105224.
[6] 马战平,阴智敏,魏耕树,等.陕西省新型冠状病毒感染的肺炎中医药治疗方案(试行第二版)[J].陕西中医,2020,41(3):275-277.
[7] 马战平,路波,王志梅,等.中研益肺解毒汤防治新型冠状病毒肺炎临床观察[J].陕西中医,2020,41(4):424-426.
[8] 刘静,龙凯花,马战平,等.基于UHPLC-Q Exactive Focus MS/MS的益肺解毒颗粒化学成分分析[J].中国药学杂志,2023,58(21):1940-1954.
[9] EHRENTRAUT H,WEISHEIT C K,FREDE S,et al.Inducing acute lung injury in mice by direct intratracheal lipopolysaccharide instillation[J].J Vis Exp,2019,(149):e59999.
[10] YANG H H,DUAN J X,LIU S K,et al.A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation[J].Theranostics,2020,10(11):4749-4761.
[11] 刘慧霞,田甜,吴跃,等.玉屏风散治疗呼吸道变应性疾病研究进展[J].中医眼耳鼻喉杂志,2020,10(4):222-225.
[12] WANG Y,WANG Y,MA J,et al.YuPingFengSan ameliorates LPS-induced acute lung injury and gut barrier dysfunction in mice[J].J Ethnopharmacol,2023,312:116452.
[13] 丁敏,何芳,鲍敏,等.基于网络药理学和细胞实验探讨玉屏风散治疗慢性阻塞性肺病的作用机制[J].中成药,2024,46(7):2407-2414.
[14] 王逸凡,杨居崩,赵显芳,等.银翘散对急性肺损伤模型小鼠肺损伤的改善及作用机制[J].中国药业,2022,31(9):35-39.
[15] 沈晔,李茜,郑悦亮,等.黄芪对脂多糖诱导的小鼠急性肺损伤作用机制的研究[J].中国现代医生,2022,60(1):38-41.
[16] WEN X,CHENG M,SONG Z,et al.Molecular mechanism of honeysuckle+forsythia in treatment of acute lung injury based on network pharmacology[J].Biomed Rep,2024,20(2):32.
[17] 唐龙泉,傅梅,龚晓玲,等.黄芪甲苷通过调控Wnt-β-catenin/JAK-STAT通路对输血相关性急性肺损伤大鼠的改善作用[J].中成药,2022,44(10):3329-3332.
[18] JIA Q,WEN J,YANG Q,et al.Lonicera japonica Thunb extract ameliorates lipopolysaccharide-induced acute lung injury associated with luteolin-mediated suppression of NF-κB signaling pathway[J].J Inflamm,2023,20(1):44.
[19] 王依澜,黄德美,王飞,等.中药活性成分调节PI3K/Akt信号通路在急性肺损伤治疗中的研究进展[J].中国实验方剂学杂志,2022,28(6):223-236.
[20] MOWERY N T,TERZIAN W T H,NELSON A C.Acute lung injury[J].Curr Probl Surg,2020,57(5):100777.
[21] ZHAO A,GUO C,WANG L,et al.Xiebai San alleviates acute lung injury by inhibiting the phosphorylation of the ERK/Stat3 pathway and regulating multiple metabolisms[J].Phytomedicine,2024,128:155397.
[22] 易建华,李雯.脂多糖诱导的急性炎症小鼠模型血清促炎因子与抑炎因子表达研究[J].陕西医学杂志,2023,52(4):395-398,403.
[23] MAITY J,PAL P,PAL R,et al.Co-administration of L-Ascorbic acid and α-tocopherol alleviates arsenic-induced immunotoxicities in the thymus and spleen by dwindling oxidative stress-induced inflammation[J].Biol Trace Elem Res,2024,202(5):2199-2227.
[24] 王文龙,孙子凯,徐丽华,等.固本咳喘颗粒对实验性慢性阻塞性肺疾病大鼠胸腺指数及脾指数的影响[J].中国临床药理学杂志,2015,31(11):935-937.
[25] 古欣,李嫦红,刘燕明.清肺排毒汤对大鼠慢性支气管肺炎气道炎症及免疫功能改善作用机制[J].中华中医药学刊,2024,42(3):225-228,294.

相似文献/References:

[1]荆志强,魏维强,谷 俊,等.通腑宣肺汤对脓毒症急性肺损伤大鼠保护机制的研究*[J].陕西中医,2019,(8):987.
 JING Zhiqiang,WEI Weiqiang,GU Jun,et al.Study on the protective mechanism of the Tongfu Xuanfei decoction in sepsis rats with acute lung injury[J].,2019,(12):987.
[2]潘 蕊,乔秋杰,曾江楠,等.基于JAK2-STAT3信号通路探讨热毒宁注射液治疗大鼠急性肺损伤的作用机制[J].陕西中医,2024,(8):1021.[doi:DOI:10.3969/j.issn.1000-7369.2024.08.003]
 PAN Rui,QIAO Qiujie,ZENG Jiangnan,et al.Mechanism of Reduning injection in improving acute lung injury in rats based on the JAK2-STAT3 signaling pathway[J].,2024,(12):1021.[doi:DOI:10.3969/j.issn.1000-7369.2024.08.003]

备注/Memo

备注/Memo:
基金项目:陕西省重点研发计划项目(2022ZDXM-SF-06,2024SF-YBXM-489); 国家中医药管理局科技司科研项目; 陕西省中医药管理局新冠专项(ZYJXG-L23002); 陕西省科协青年人才托举计划项目(20230321); 西安市科技计划项目(23YXYJ0142)
更新日期/Last Update: 2024-12-05